Advertisement
Home 2017 August

Monthly Archives: August 2017

Awake brain surgery may improve treatment of brain aneurysms

Being Awake for Aneurysm Brain Surgery May Offer Better Results

0
In new approach to the dangerous lesions, surgeons can get patient feedback during the procedure
Too many patients with migraines are prescribed opioids

Opioids Often Prescribed Unnecessarily for Migraine

0
And many patients may not be getting recommended medications
Bicyclist deaths on U.S. roadways are up significantly

Cycling Crash Deaths Rising in the United States

0
Fatal crashes jumped 12 percent in 2015, according to government report
In healthy

Thoracic Kyphosis Not Tied to Physical Function

0
Findings based on follow-up from the Framingham Heart Study
There is a positive relationship between attitude toward aesthetic dermatology treatments and emotional well-being

Links Between Emotional Well-Being, Aesthetic Dermatology

0
Greater knowledge of aesthetic dermatology tied to better emotional well-being
Six out of 10 U.S. teens ages 13 to 17 received one or more doses of a human papillomavirus vaccine in 2016

CDC: More U.S. Teens Starting HPV Vaccination

0
60.4 percent received one or more doses in 2016, but many not completing series
Only one in three heart attack survivors in the United States attends outpatient cardiac rehabilitation

Only One-Third of Heart Attack Patients Enter Cardiac Rehab

0
Reasons why not include race, age, education level, and insurance
A minimally invasive surgery approach is increasingly being used for paraesophageal hernia (PEH) repair

Minimally Invasive Sx Use Up for Paraesophageal Hernia Repair

0
In 2012, MIS approach used in ~80 percent of PEH repairs; increase linked to reduction in mortality
For patients with psoriasis receiving long-term methotrexate sodium therapy

Noninvasive Test for NASH, Fibrosis in Patients With Psoriasis

0
Correlation for cumulative methotrexate dose with higher score on NASH FibroSure in women
At its current price

More Evidence Evolocumab Exceeds Cost-Effectiveness

0
Findings for addition of evolocumab to standard tx in atherosclerotic cardiovascular disease